(Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | (Q3)Oct 31, 2023 | (Q2)Jul 31, 2023 | (Q1)Apr 30, 2023 | (FY)Jan 31, 2023 | (Q4)Jan 31, 2023 | (Q3)Oct 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 106.48%15K | -104.49%-1.84K | 19.92%-87.27K | 194.68%108.95K | -113.68%-5.65K | -936.22%-231.53K | 418.79%40.97K | 46.09%-108.97K | -137.20%-115.06K | 162.13%41.29K |
Net income from continuing operations | -31.15%-105.7K | 154.42%94.58K | -124.16%-628.62K | 13.77%-132.7K | -222.59%-241.53K | 59.55%-80.6K | -217.76%-173.79K | -680.29%-280.44K | 20.33%-153.89K | 65.93%-74.87K |
Operating gains losses | ---120.92K | --10.24K | -64.13%52.22K | ---- | ---- | ---- | ---- | 315.11%145.6K | 3,826.56%237.91K | 638,640.00%127.75K |
Depreciation and amortization | 0.00%2.33K | 0.00%2.33K | 0.00%9.31K | 0.00%2.33K | 0.00%2.33K | 0.00%2.33K | 0.00%2.33K | 19.72%9.31K | 16.69%2.33K | 5.29%2.33K |
Asset impairment expenditure | ---- | ---- | -43.57%206.11K | -43.34%206.11K | ---- | ---- | ---- | 777.00%365.26K | 778.82%363.74K | 1,072.20%3.04K |
Unrealized gains and losses of investment securities | 681.56%53.34K | -127.15%-44.97K | 1,528.51%153.69K | 26.31%-84.93K | 195.51%82.14K | -106.30%-9.17K | 269.43%165.65K | -108.64%-10.76K | -166.61%-115.26K | -305.78%-86.01K |
Remuneration paid in stock | --0 | --14.58K | --115.83K | --0 | --115.83K | --0 | --0 | --0 | --0 | ---- |
Deferred tax | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---17.7K | ---- | ---- |
Other non cashItems | 47,561.02%121.06K | -42,337.41%-120.8K | 87.13%-47.05K | 99.97%-97 | -454.99%-47.5K | -98.01%254 | 103.30%286 | -7.04%-365.69K | -721.42%-361.25K | -647.19%-8.56K |
Change In working capital | 144.98%64.92K | -9.27%42.18K | 12.75%51.24K | 193.06%66.02K | 7.04%83.08K | -583.50%-144.35K | 421.67%46.49K | 169.18%45.44K | -606.13%-70.94K | 251.80%77.61K |
-Change in receivables | 138.54%2.16K | -71.34%10.66K | 196.75%28.76K | 51.54%-12.01K | 139.27%9.16K | 38.71%-5.59K | 35.22%37.21K | 55.06%-29.73K | 33.80%-24.79K | 29.27%-23.33K |
-Change in prepaid assets | 137.41%15.06K | 117.64%9.48K | -1,360.14%-20.93K | 8,207.93%42.95K | 726.13%30.1K | -913.75%-40.26K | -3,749.66%-53.72K | 182.23%1.66K | -92.70%517 | 227.47%3.64K |
-Change in payables and accrued expense | 148.43%47.71K | -65.02%22.04K | -40.95%43.41K | 175.16%35.08K | -54.96%43.82K | -329.32%-98.5K | 413.88%63.01K | 2,868.78%73.51K | -329.79%-46.67K | 736.39%97.3K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 106.49%15.03K | -104.56%-1.87K | 19.92%-87.27K | 194.68%108.95K | -113.68%-5.65K | -936.22%-231.53K | 418.79%40.97K | 46.09%-108.97K | -137.20%-115.06K | 162.13%41.29K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -12.44%-142.25K | 48.85%-23.76K | 0.88%-235.62K | -134.49%-20.39K | 68.14%-42.27K | -14.41%-126.51K | 13.34%-46.46K | -31.47%-237.72K | 478.62%59.12K | 33.34%-132.66K |
Net PPE purchase and sale | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 210.00%155K | 100.00%100K | --0 |
Net investment purchase and sale | --0 | --16.97K | -27.59%36.82K | 140.59%36.82K | --0 | --0 | --0 | -81.13%50.85K | 32.14%15.3K | 244.00%32.68K |
Net other investing changes | -12.44%-142.25K | 12.32%-40.73K | 38.58%-272.44K | -1.83%-57.21K | 74.44%-42.27K | -11.52%-126.51K | 57.23%-46.46K | 11.33%-443.57K | 68.29%-56.18K | -52.39%-165.34K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -12.44%-142.25K | 48.85%-23.76K | 0.88%-235.62K | -134.49%-20.39K | 68.14%-42.27K | -14.41%-126.51K | 13.34%-46.46K | -31.47%-237.72K | 151.14%59.12K | -34.00%-132.66K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -98.28%4.9K | 3,383.53%85.31K | 259.16%237.47K | -157.64%-42.6K | 0.12%-2.59K | 11,092.49%285.26K | -0.08%-2.6K | -88.80%66.12K | -73.51%73.91K | -25.82%-2.6K |
Net issuance payments of debt | -0.04%-2.6K | 0.15%-2.59K | -385.25%-50.38K | -1,541.50%-42.6K | 0.12%-2.59K | 0.00%-2.6K | -0.08%-2.6K | -148.64%-10.38K | 27.35%-2.6K | -25.82%-2.6K |
Net common stock issuance | -97.39%7.5K | --87.9K | 295.75%302.75K | -80.52%14.9K | --0 | --287.85K | --0 | -87.03%76.5K | -74.80%76.5K | --0 |
Net other financing activities | ---- | ---- | ---14.9K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -98.28%4.9K | 3,383.53%85.31K | 259.16%237.47K | -157.64%-42.6K | 0.12%-2.59K | 11,092.49%285.26K | -0.08%-2.6K | -88.80%66.12K | -73.51%73.91K | -25.82%-2.6K |
Net cash flow | ||||||||||
Beginning cash position | -11.32%138.36K | -52.05%78.68K | -63.10%164.1K | -77.61%32.72K | -65.34%83.23K | -58.46%156.02K | -63.10%164.1K | 87.37%444.68K | -36.41%146.14K | -51.72%240.11K |
Current changes in cash | -68.05%-122.32K | 838.10%59.68K | 69.55%-85.42K | 155.84%45.96K | 46.25%-50.51K | 46.29%-72.79K | 88.29%-8.09K | -235.31%-280.58K | -91.64%17.96K | 64.87%-93.97K |
End cash Position | -80.74%16.03K | -11.32%138.36K | -52.05%78.68K | -52.05%78.68K | -77.61%32.72K | -65.34%83.23K | -58.46%156.02K | -63.10%164.1K | -63.10%164.1K | -36.41%146.14K |
Free cash from | 106.49%15.03K | -104.56%-1.87K | 19.92%-87.27K | 194.68%108.95K | -113.68%-5.65K | -936.22%-231.53K | 418.79%40.97K | 46.09%-108.97K | -137.20%-115.06K | 162.13%41.29K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data